[1]
B. M. F. Arkawazi, “Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline”, Al-Kindy Col. Med. J, vol. 15, no. 2, pp. 50–57, Jan. 2020, doi: 10.47723/kcmj.v15i2.161.